NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics

Percentage of screen-positive patients who received a safety plan intervention during the baseline visit. The baseline visit is defined as the clinic visit during which a participant screens positive for suicide risk and is identified for study follow-up procedures.

Percentage of screen-positive patients who were seen by a provider at the school clinic within 3 months of baseline visit.

Suicidal Ideation Questionnaire (SIQ-Jr) will be administered to participants two times within 3 months of the baseline visit. The SIQ-Jr is a 15-item self-report questionnaire that measures suicidal thoughts on a 7-point scale ("0- I never had this thought" to "6- I have this thought every day"). Scores range from 0-90, SIQ-Jr scores of 30 and above indicate severe suicidal ideation and the need for clinical intervention.

The Center for Epidemiological Studies Depression Scale (CES-D) will be administered to participants two times within 3 months of the baseline visit. The CES-D is a self-report measure with 10 items asking about the frequency with which individuals have experienced various symptoms of depression within the last week. Each item is rated on a Likert scale, typically ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range is from 0-30, with higher scores indicating higher levels of depression.

The Client Satisfaction Questionnaire (CSQ) will be administered to participants two times within 3 months of the baseline visit. The CSQ is a self-report measure with 8 Likert-style items asking about satisfaction with services received at the clinic. Total scores range is from 8-32, with higher scores indicating higher levels of service satisfaction.

Participants will be administered the brief version of the Columbia Suicide-Severity Rating Scale (C-SSRS) two times within 3 months of the baseline visit. The C-SSRS is a screening tool that asks two initial questions about suicidal ideation. For participants who state "yes" to either of these questions, they are asked additional questions about suicidal intent, plans, and behavior. Investigators will measure suicidal behavior as a dichotomous "yes"/"no" variable. A participant will be considered a "yes" for this measure if they answer "yes" to the final question about engaging in suicidal preparation and/or attempts on the C-SSRS and to the question asking whether or not they have done so in the past 3 months.

Percentage of participants with a positive suicide risk screen who report using the safety plan developed during the baseline visit. Safety plan use will be assessed during follow-up evaluations conducted after the baseline visit.

Percentage of Parents of screen-positive participants reporting use of the safety plan developed during the participant's baseline visit. Safety plan use will be assessed during follow-up evaluations conducted after the baseline visit.

Participant ratings of safety plan helpfulness measured using a 4-point Likert scale ranging from 1 (Very Helpful) to 4 (Not at All Helpful). Lower scores indicate greater perceived helpfulness of the safety plan.

Parent ratings of safety plan helpfulness measured using a 4-point Likert scale ranging from 1 (Very Helpful) to 4 (Not at All Helpful). Lower scores indicate greater perceived helpfulness of the safety plan.

Number of participants who report acute care was utilized for help with suicidal symptoms between the baseline visit and the 3 month follow up visit per participant report.

Number of parents who report acute care was utilized for help with suicidal symptoms of the participant between the baseline visit and the 3 month follow up visit per participant report.